drugset / Trial / NCT02079506

Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin

NCT02079506

Phase 1 Completed 40 enrolled Alvogen Korea
Non-randomizedCrossoverOpen-labelTreatment

Summary

The objective of this study is to compare pharmacokinetics after single oral administration of candesartan and rosuvastatin each separately versus coadministration of candesartan and rosuvastatin in healthy male volunteers.

Timeline

Start
2014-02
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan Unknown
Subject Rosuvastatin Small molecule

Indications

No indication recorded.